Cat-Scratch Disease

Comprehensive Clinical Guide: Cat-Scratch Disease (CSD)

Cat-Scratch Disease (CSD), or Bartonellosis, is a zoonotic infectious disease caused by the gram-negative bacterium Bartonella henselae. While historically considered a benign, self-limiting condition primarily affecting pediatric and young adult populations, it remains a significant diagnostic challenge due to its polymorphic clinical presentation. In immunocompromised individuals, the disease can manifest as severe, systemic, and potentially life-threatening complications, including bacillary angiomatosis and peliosis hepatis.

This guide serves as an authoritative resource for clinicians, medical students, and healthcare professionals to navigate the etiology, pathophysiology, diagnostic algorithms, and therapeutic management of Bartonella infections.

1. Etiology and Pathophysiology

The Causative Agent

Bartonella henselae is a fastidious, facultative intracellular, aerobic, gram-negative rod. It is primarily transmitted to humans via the scratch or bite of a domestic or feral cat, specifically kittens, which act as the primary reservoir for the bacteria.

• Vector Transmission: The cat flea (Ctenocephalides felis) is the primary vector responsible for horizontal transmission among cats.
• Human Transmission: Humans become accidental hosts through direct inoculation into the dermis.
• Intracellular Mechanisms: Once inoculated, the bacteria attach to host cells—predominantly erythrocytes and endothelial cells—via adhesins such as BadA (Bartonella adhesin A). The bacterium employs a Type IV Secretion System (T4SS) to inject effector proteins into the host cell, modulating apoptosis and promoting angiogenesis, which explains the vascular proliferative lesions observed in disseminated disease.

2. Clinical Staging and Presentation

CSD typically follows a predictable timeline, though systemic involvement can disrupt this progression.

Clinical Staging Table

Key Clinical Features

1. Regional Lymphadenopathy: The hallmark of CSD. Nodes are typically tender, firm, and may undergo suppuration (formation of pus) in 10-30% of cases. Common sites include axillary, cervical, and submandibular chains.
2. Oculoglandular Syndrome of Parinaud: A rare presentation involving unilateral conjunctivitis associated with preauricular lymphadenopathy.
3. Neuroretinitis: Sudden, painless vision loss accompanied by optic disc edema and macular star formation.
4. Hepatosplenic CSD: Characterized by prolonged fever of unknown origin (FUO) and multiple hypoechoic lesions in the liver and spleen on ultrasound or CT scan.

3. Diagnostic Algorithmic Approach

Diagnosing CSD requires a high index of suspicion, especially in patients with a history of cat exposure or persistent lymphadenopathy.

Diagnostic Modalities

• Serology (IFA/ELISA): The most common diagnostic tool. Detection of IgG and IgM antibodies against B. henselae. High sensitivity but potential for cross-reactivity with B. quintana.
• PCR (Polymerase Chain Reaction): Highly specific. Recommended for lymph node aspirates, blood, or tissue biopsies.
• Histopathology: Warthin-Starry silver staining of lymph node biopsies reveals clusters of pleomorphic, gram-negative rods.
• Imaging: Abdominal ultrasound or CT with contrast is mandatory if hepatosplenic involvement is suspected.

Differential Diagnosis

The clinical presentation of CSD often mimics more serious conditions, necessitating a thorough rule-out process:
* Malignancy: Lymphoma, metastatic carcinoma.
* Infectious: Tuberculosis (scrofula), Tularemia, Infectious Mononucleosis (EBV/CMV), Toxoplasmosis.
* Autoimmune: Sarcoidosis, Kawasaki disease.

4. Therapeutic Management and Prognosis

Standard Treatment

In immunocompetent patients with mild, self-limiting lymphadenopathy, supportive care (analgesics, warm compresses) is the standard of care. Antibiotics are generally reserved for:
1. Severe, systemic disease.
2. Immunocompromised patients.
3. Patients with prolonged, painful lymphadenopathy.

Recommended Regimens:
* Azithromycin: The drug of choice. 500mg on day 1, followed by 250mg for 4 days.
* Alternative Agents: Doxycycline, Rifampin, or Ciprofloxacin for systemic or neurological complications.

Long-Term Prognosis

• Immunocompetent: Excellent. Spontaneous resolution is expected. Rare sequelae include chronic fatigue or residual scarring.
• Immunocompromised: High risk of disseminated disease (Bacillary Angiomatosis). Requires prolonged treatment (up to 3-6 months) and intensive monitoring.

5. Risks, Side Effects, and Contraindications

While rare, systemic complications can be severe:
* Encephalopathy: Occurs in <1% of patients, typically 2-6 weeks after the onset of lymphadenopathy. Presents with seizures, confusion, or coma.
* Osteomyelitis: Lytic bone lesions, typically involving the vertebral bodies or pelvic bones.
* Contraindications: Avoid surgical excision of suppurative lymph nodes unless necessary for diagnosis, as it can lead to chronic sinus tract formation.

6. Frequently Asked Questions (FAQ)

1. Is Cat-Scratch Disease contagious between humans?

No. There is no evidence of human-to-human transmission. The disease is strictly zoonotic.

2. Do all cats carry Bartonella?

Not all, but a significant portion of domestic cats, particularly young kittens (<1 year), carry the bacteria in their saliva and blood.

3. How can I prevent CSD?

Flea control is the most effective preventative measure. Avoid rough play with kittens, and wash hands thoroughly after contact with cats.

4. Can you get CSD more than once?

Yes, reinfection is possible, though it is rare as the host generally develops protective immunity.

5. What is the significance of the "macular star"?

It is a diagnostic sign of neuroretinitis, indicating inflammation of the optic nerve and surrounding retinal tissue, often linked to Bartonella infection.

6. Are there specific tests for cats?

Yes, veterinarians can test cats for Bartonella, but treatment of healthy cats is not recommended as it does not reliably eliminate the bacteria.

7. Does the scratch have to be deep?

No. The bacteria can be inoculated through minor scratches or licks to broken skin or mucous membranes.

8. Is CSD a reportable disease?

In many jurisdictions, it is not a mandatory reportable condition, but reporting is encouraged to track zoonotic outbreaks.

9. What should I do if a lymph node is draining pus?

Seek medical consultation. Do not attempt to drain it yourself; antibiotics and professional wound management are required to prevent secondary infection.

10. Can CSD cause permanent vision loss?

If left untreated, severe neuroretinitis can lead to permanent visual field defects. Early diagnosis and antibiotic intervention usually result in a complete recovery of visual acuity.

7. Clinical Summary Table

Conclusion

Cat-Scratch Disease is a multifaceted infection that demands clinical vigilance. While the majority of cases resolve without intervention, the potential for neurological, ocular, and systemic involvement necessitates a structured approach to diagnosis and treatment. Clinicians must maintain a high index of suspicion in patients presenting with unexplained lymphadenopathy and a history of feline exposure. Through proper patient education—specifically regarding flea control and safe handling of pets—the incidence of this zoonotic disease can be significantly mitigated in the community.

This guide serves as a foundational clinical resource. For specific pediatric or immunocompromised cases, consultation with an infectious disease specialist is highly recommended to tailor antibiotic regimens and monitor for potential systemic sequelae.